Long-term care pharmacy agrees to pay over $5.3 million to resolve prescription-billing allegations
Sep 27, 2026 edition · GC-2026-0122 · Published 2026-09-27 · Version 2 · Settled
Remedi SeniorCare agreed to pay more than $5.3 million over allegations of Medicare and Medicaid claims for drugs lacking valid prescriptions; payment is based on ability to pay and made over time.
What happened
DOJ announced September 17, 2026 that Remedi SeniorCare Holding Corporation agreed to pay more than $5.3 million to resolve False Claims Act allegations involving drugs dispensed without valid prescriptions. The government alleged false Medicare and Medicaid claims from January 1, 2015 through March 31, 2021 for drugs supplied to assisted-living residents in various states. The release says the settlement reflects Remedi's ability to pay and will be paid over time. It does not establish that the full amount had already been collected by this edition’s coverage cutoff.
The resolution includes claims raised by two former employees under the False Claims Act's whistleblower provisions, with a share of payments to be paid to them over time. The announcement expressly says the settled claims are allegations only and there has been no determination of liability. The case therefore supports a focused review of prescription-validity and billing safeguards rather than a conclusion that every resident's prescription was invalid or that the company was convicted. Facilities and pharmacy partners should distinguish the resident's need for continued medication from the separate requirement to retain a valid, timely prescribing basis for dispensing and reimbursement.
Scope and timing
- Authority status
- Settled
- Applicability
- Operationally relevant
- Audience
- Health systems, Provider networks
- Jurisdiction
- Federal, Maryland
Why it matters
Long-term care medication workflows need reliable prescriber-order evidence and claim controls when prescriptions are missing, expired or otherwise invalid.
Recommended action
Audit prescription-validity checks, order retention, emergency and refill workflows, and claim edits. Resolve missing or expired orders with clinical and pharmacy teams without inferring that operational recommendations are new settlement-wide rules.
Case details
- agencies
- HHS Office of Inspector General
- entities
- Remedi SeniorCare
- action Type
- Settlement
- event Date
- 2026-09-17
- alleged Conduct
- Billing federal healthcare programs for drugs allegedly dispensed without valid prescriptions.
- resolution
- Agreement to pay more than $5.3 million based on ability to pay and in installments over time, resolving disputed civil False Claims Act allegations; no liability determination or completed collection established.
Operational lessons
- Validate prescription authority before dispensing and billing.
- Retain accessible prescriber-order evidence.
- Use claim edits to stop billing when required order data is missing.
Sources
- Maryland Long-Term Care Pharmacy Pays $5.3M to Settle Allegations of Billing for Drugs Without Valid PrescriptionsOfficial · HHS Office of Inspector General · 2026-09-18 · Source review 2026-09-20
- Official retained source documentOfficial · Official issuing agency · 2026-09-17 · Source review 2026-10-15
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Enforcement Briefing report →